Table 3. Univariate and multivariate Cox’s regression analyses for OS and DFS in colorectal cancer patients.
Variable | DFS | OS | |||||||
---|---|---|---|---|---|---|---|---|---|
Univariate P | Multivariate | Univariate P | Multivariate | ||||||
HR | 95% CI | P | HR | 95% CI | P | ||||
Gender: male vs. female | 0.904 | 0.427 | |||||||
Age: <65 vs. ≥65 | 0.116 | 0.101 | |||||||
Vascular invasion | 0.065 | 1.610 | 0.795–3.259 | 0.186 | 0.007 | 1.950 | 0.935–4.064 | 0.075 | |
Perineural invasion | 0.867 | 0.385 | |||||||
Serum CEA: normal vs. elevated | 0.208 | 0.049 | 1.735 | 0.937–3.214 | 0.080 | ||||
Tumor location: right vs. left colon | 0.954 | 0.695 | |||||||
Differentiation: well vs. poorly | 0.135 | 0.193 | |||||||
T stage: T1, 2 vs. T3, 4 | 0.007 | 0.003 | |||||||
N stage: N0 vs. N1, 2 | 0.011 | 0.006 | |||||||
TNM: I, II vs. III, IV | 0.001 | 2.102 | 1.302–3.392 | 0.002 | 0.000 | 2.356 | 1.315–4.222 | 0.004 | |
Post-surgical chemotherapy: no vs. yes | 0.164 | 0.399 | |||||||
RANBP9: low vs. high expression | 0.017 | 0.580 | 0.356–0.946 | 0.029 | 0.061 | 0.553 | 0.309–0.989 | 0.046 |
DFS, disease free survival; OS, overall survival; CEA, carcinoembryonic antigen; TNM, tumor node metastasis; RANBP9, RAN-binding protein 9.